Protagonist Therapeutics, Inc

PTGX us
$141.86
▲ +4.52 (+3.29%)
Volume: 809,192 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 43
  • 21d momentum -6.4%
  • RSI 46
🎯 Pullback 50
  • -1.9% vs 20MA
💎 Value 50
  • No fundamental data

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)46.0
MACD-0.919
MA trendMixed
ATR3.84%
21d mom.-6.4%
63d mom.+16.4%
vs 20MA-1.9%
RVOL(20)1.25×
52w low · 62 52w high · 161
-11.8% from 52-week high
20d support 134 · resistance 151

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$8.9B
PER107.19
PBR10.56
PSR31.52
EPS$1.28
ROE9.8%
ROA9.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA142.34
week1M3M6M1YYTD
-0.80% -6.36% +16.39% +38.85% +115.10% +62.72%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
4/10
🐻 Bear
7/10

14d momentum -2.65%, daily vol 1.87%. Protagonist Therapeutics, Inc sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.